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Abstract 
 Cinnamon extract are widely used in Middle East and Asian countries as herbal 
medication for diabetes. The study evaluates the effects of Cinnamon aqueous extract on 
blood glucose level, liver biomarker enzymes, hematological and lipid profile parameters in 
alloxan- induced diabetic male albino rats (Wistar strain). Adult male albino rats weighing 
between 170-220g were induced intraperitoneally with alloxan. The male albino rats were 
grouped into five groups of six animals per group.  Group A is the normal control group, 
Group B served as the negative control, Group C served as positive control and was treated 
with glibenclamide, Group D and  E were treated with 100 and 200 mg/kg body weight of  
cinnamon aqueous extract respectively. The extracts were given to the animals orally for 14 
days.  At the end of the experimental period, the albino rats from each experimental group 
were starved for 16 hours and sacrificed by cervical dislocation. The weight of diabetic 
untreated rats (Group B) were significantly (P<0.005) reduced when compared to other 
groups. The animals treated with glibenclamide, 100 and 200mg/Kg  body weight of 
cinnamon extract showed significant decrease (P<0.05) of blood sugar level compared to the 
untreated rats (group B). This suggests that the plant extract possesses anti-diabetic and 
hypoglycemic effect. The extracts significantly increased RBC, HGB and HCT; and the WBC 
was significantly reduced in the treated groups compared to the untreated group. There were 
significant decrease (P<0.05) in plasma TC, TG, LDC-Cholesterol and an increase in HDL-
Cholesterol values was observed in the treated groups compared to the untreated group. This 
is an indication that the extract had hypolipidemic effect and can be used in the treatment of 
diabetes. The extract significantly increased (P<0.05) plasma total protein level in the treated 
groups. The extract significantly reduced (P<0.005) liver biomarker enzymes (AST, ALT and 
ALP), an indication that it does not have effect on the liver.  
 
Keywords: Alloxan-induced diabetic rats, Cinnamon aqueous extract, hematological 
parameters, hypoglycemic effect, lipid profiles and liver biomarker enzymes 
 
Introduction 
 Diabetes mellitus (DM) is one of the major complex and chronic disorders of 
carbohydrate, lipid, and protein metabolism characterized by persistent elevation of blood 
glucose, resulting from a partial or complex cessation of insulin secretion or synthesis, or 
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peripheral resistance to insulin action. In diabetic patients, the body loses insulin producing 
capacity as a result of pancreatic β- cell apoptosis or insulin insensitivity. The cytokines, lipo-
toxicity and gluco-toxicity are three major stimuli for β-cell apoptosis (Hui et al 2004). 
Medicinal plants constitute an effective source of both traditional and modern medicines, 
herbal medicine has been shown to have genuine utility and about 80% of rural populations 
depend on it as primary health care. Diabetic nephropathy is one of the major causes of 
morbidity and premature mortality in patients with insulin-dependent DM. Medicinal plants 
contain potentially useful chemicals that serve as basis for the manufacturing of modern 
medicines (Okigbo et al., 2009). Cinnamon is the bark of the Cinnamon cassiae, it contain 
cinnamon anhydride,tannin, cinnamic acid and methyl-hydroxychalcone polymer (MHCP) 
etc. Cinnamon has a long history as an anti-diabetic spice, but trials involving cinnamon 
supplementation have produced contrasting results (Kirkham et al 2009).  Mang et al 2006 
show that cinnamon extract seems to have a moderate effect in reducing fasting plasma 
glucose concentrations in diabetic patients with poor glycaemic control. 
 
Methodology 
Cinnamon extract preparation 
 Cinnamon aqueous extract was extracted based on method of sheng et al 2008. 
Cinnamon powder 200g was dissolved in 1000 ml double distilled water then subjected for 
revolving evaporator in vacuum state using vacuum pump till the volume of water reduced to 
about 50%. The supernatant was filtered using Whatman filter paper to obtain cinnamon 
extract.   
 
Animals and biochemical Assay 
Sources of animals  
 Male Wistar albino rats of 170 to 220g body weight (B.WT) were obtained from 
University of Lagos Idi-araba, Lagos- Nigeria. These animals were maintained under 
laboratory conditions of temperature (22 to 24°C), humidity (40 to 60%) and 12 hour light/12 
hour dark regime at Lagos State polytechnic Ikorodu animal house. They were exposed to 
both food and water ad libitum for the entire duration of the study. All animals used for this 
study were maintained according to the rules and regulations outlined in accordance with NIH 
Guide for the care and use of laboratory animals; NIH Publication revised (1985) NIPRD 
Standard Operation Procedures (SOPs). 
 
Administration of alloxan 
 Male albino rats (Wistar strain) of about fifteen weeks old with average weight of 
186g were made diabetic by injecting them with alloxan monohydrate intraperitoneally with 
dosage of 150mg/kg body weight (Pari and Venkateswaran, 2002). Development of diabetes 
was confirmed after 72 hours of alloxanisation by using “Accuchek Active Glucometer” 
(Roche Diagnostics) and blood glucose test strips                                                                                                                     
 
Grouping of animals 
 The animals were grouped into five groups of six animals per group as shown below: 
 Group A – normal control ( non-diabetic rats ) 
 Group B- Negative control (diabetic without treatment)  
 Group C- Positive control (diabetic + glibenclamide)  
 Group D- Diabetic + 100mg/Kg B.WT of Cinnamon aqueous extract   
 Group E- Diabetic + 250mg/Kg B.WT of Cinnamon aqueous extract 
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Determination of hematological parameters 
  The total red blood cell (RBC), hemoglobin concentration (HGB) ,white blood cell 
count (WBC), platelet count and other hematological parameters were determined in the 
blood using BC-3200 Auto Hematology Analyzer in University of Lagos Teaching Hospitals 
(LUTH) in Idi-araba, Lagos, Nigeria.  
 
Collection of blood samples for plasma preparation 
  The rats were sacrificed by cervical dislocation. Blood samples were collected by 
ocular punctures into heparinized tubes. The blood was later centrifuged for 10mins at 
3000rpm using a centrifuge. The clear supernatant was used for the estimation of total 
protein, lipid profiles and liver function tests.  
 
Determination of plasma lipid profiles 
  The plasma total cholesterol, triglyceride and HDL-Cholesterol were determined 
using Randox diagnostic kit [Trinder,1969 and Tietze, 1990]. Low density Lipoprotein-
Cholesterol (LDL-C) was calculated using formula from [Friedwald, et al 1972].  
 
Determination of liver function tests  
 Plasma enzymes like alkaline phosphatase (ALP), aspartate aminotransferase (AST), 
and alanine aminotransferase (ALT) were determined using Randox diagnostic kits. The total 
protein in the plasma was also determined using Randox kit.  
 
Data Analysis 
 Data analysis was done using the GraphPad prism computer software. Students ‘t’-test 
and one-way analysis of variance (ANOVA) were used for comparison. A P-value < 0.05 was 
considered significant. 
 
Results 
 Table 1 below shows that Cinnamon extract and the standard drug have 
hypoglycaemic effects on alloxan-induced diabetic rats. 
Table 1.  Effect of standard drug (glibenclamide) and  Cinnamon extract (100 and 200mg/Kg B.W) on blood 
glucose level of  albino rats induced with alloxan.  
Groups 
Initial glucose 
concentration (mg/dl) 
 
Glucose conc. 
after Alloxan 
induction 
(mg/dl) 
Day 0 
Glucose conc after 
7 days of treatment 
(mg/dl) 
Glucose conc. after 
14 days of 
treatment (mg/dl) 
Group A 98 ±10 104 ±11 100 ±11 107 ±13 
Group B 98 ±7 436±21 443±33 461±43 
Group C 96 ±10 461±32 212 ±40 97 ±14 
Group D 101 ±12 417±31 289 ±85 137 ±12 
Group E 93 ±11 438±49 274 ±82 123  ±11 
 Group A animals were not induced with Alloxan while Group B were induced and not treated. 
 
 The standard drug (glibenclamide), reduces the blood sugar level by 79.9% while 100 
and 200 mg/Kg body weight of cinnamon extract reduce the blood sugar level by 61.1% and 
67.8%  respective (Table 1 above).  
 
Determination of animal body weight 
 There is a progressive decrease in the body weight of diabetic untreated rats compared 
to other rats in other groups. As expected, alloxan-induced diabetic rats showed all the 
characteristic of diabetes such as polyuria, polyphagia, polydipsia and loss of body weight. 
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This is evident from figure I, below. Group B (diabetes untreated animals) albino rats have 
significant (P<0.05) weight lost compared to other groups. 
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Figure 1: Mean body weight (g) of normal, Diabetic untreated, Diabetic rats treated with glibenclamide, 100 and 
200mg/kg body weight of Cinnamon extract. 
 
Table 2.  The effect of Cinnamon extract and glibenclamide on hematological parameters of male albino rats 
induced with alloxan..   
Hematological 
parameters GROUP A GROUP B GROUP C GROUP D GROUP E 
WBC (×109/L) 9.3 ± 1.1* 15.2±2.1 11.1±2.3* 10.2±1.4* 9.8 ±1.2* 
HGB g/dl 13.1 ± 1.3* 8.9 ± 2.6 12.2 ± 1.2* 13.8 ± 1.6* 14.4 ± 1.9* 
RBC (×1012/L) 7.8 ± 1.6* 5.3 ± 1.8 7.0 ± 1.2* 6.9± 0.8* 7.4 ± 1.8* 
HCT % 44.3 ± 2.1* 29.2 ± 7.2 46.1 ± 1.1* 49.3 ± 1.5* 47.2 ± 1.8* 
MCV fl 62.0 ± 1.0 59.1 ± 2.4 59.3 ± 0.5 62.3 ± 1.2 58.8 ± 1.2 
MCH pg 19.1 ± 1.3 18.2 ± 0.8 18.5 ± 1.1 19.2 ± 0.9 19.1 ± 1.1 
MCHC g/dl 31.2 ± 0.8 31.7 ± 1.0 31.6 ± 1.2 29.4 ± 1.1 31.1 ± 0.7 
RDW-CV % 16.8 ± 0.6 16.1 ± 0.7 16.9 ± 0.8 16.4± 1.1 16.7 ± 0.9 
RDW-SD fl 35.5 ± 1.1 32.1 ± 1.5 33.6 ± 0.8 38.4 ± 1.4 36.7 ± 0.7 
MPV fl 6.7 ± 0.4 7.9 ± 0.8 7.1 ± 0.5 7.0± 0.4 6.5 ± 0.4 
PDW 16.4 ± 0.7 16.3 ± 0.4 16.0 ± 0.4 16.1 ± 0.3 15.8 ± 0.6 
PCT % 0.411 ± 0.017 0.420 ± 0.023 0.345 ± 0.011 0.361 ± 0.154 0.386 ± 0.199 
 
 The values are the Means ± SD for six rats in each group. White blood count (WBC), 
Hemoglobin (HGB), Red blood count (RBC), Hematocrit (HCT),Mean cell volume(MCV), 
Mean corpuscular hemoglobin (MCH), Mean corpuscular hemoglobin concentration 
(MCHC), Red Blood Cell Distribution Width Coefficient of Variation (RDW-CV),  Red 
Blood Cell Distribution Width Standard Deviation (RDW-SD), Mean platelet volume 
(MPV),platelet Distribution Width (PDW) and Plateletcrit (PCT). 
 The different hematological parameters of the entire experimental groups (group A to 
E) are shown in Table 2 above. 
Table 3. The effect Cinnamon extract on lipid profiles in alloxan–induced diabetic male  rats.  
Parameters Group A Group B Group C Group D Group E 
Total Cholesterol (mg/dl) 71.3 ± 4.5* 98.4 ±6.5 80.1± 6.7* 75.3 ±5.3* 73.5 ±4.9* 
Triglyceride (mg/dl) 82.4±3.2* 143.2±4.30 104.2 ±6.8* 99.4 ±5.9* 93.5±4.8* 
Low-density Lipoprotein 
(mg/dl) 10.1 ±0.5* 44.6± 1.60 22.6 ±2.4* 16.4 ±2.8* 13.6 ±3.1* 
High-density Lipoprotein 
(mg/dl) 46.2 ±4.2* 25.3 ±5.70 37.2 ±3.4* 39.6 ±4.8* 40.2±2.9* 
* indicate Significant difference (P <0.05) when comparing normal and treated group with negative control 
group. 
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 Cinnamon extract significantly reduces (P<0.05) the plasma level of TC, TG and 
LDL-Chol in the treated animals compared to the untreated animals. The plasma HDL-Chol 
of the treated animals is enhanced by the administration of the extracts (Table 3).  
 
The effect of Cinnamon extract on plasma liver marker enzymes and total protein in 
healthy and  alloxan–induced diabetic male rats.  
Figure 2 below shows that cinnamon extract significantly reduces plasma Aspartate aminotransferase  (AST) in 
alloxan-induced diabetic rats.   
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Figure 2. Plasma Aspartate aminotransferase (AST) values of normal, Diabetic untreated,
Diabetic rats treated with glibenclamide, 100 and 200mg/kg body weight of Cinnamon extract.
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Figure 3 below shows that cinnamon extract significantly reduces plasma Alanine aminotransferase  (ALT) in 
alloxan-induced diabetic rats. 
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Figure 3. Plasma Alanine aminotransferase (ALT) values of normal, Diabetic untreated,
Diabetic rats treated with glibenclamide, 100 and 200mg/kg body weight of Cinnamon extract.
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Figure 4 below shows that cinnamon extract significantly reduces plasma Alkaline Phosphatase (ALP) in 
alloxan-induced diabetic rats. 
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Figure 4. Plasma Alkaline Phosphatase (ALP) values of normal, Diabetic untreated, Diabetic
rats treated with glibenclamide, 100 and 200mg/kg body weight of Cinnamon extract.
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Figure 5. Plasma Total Protein values of normal, Diabetic untreated, Diabetic rats treated
with glibenclamide,100 and 200mg/kg body weight of Cinnamon extract.
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Figure 5 above shows that cinnamon extract significantly increases plasma total protein in alloxan-induced 
diabetic rats.   
 
Discussion 
 Several hypoglycemic herbs have been used as non-prescription treatment for 
diabetes. Few herbal medicines have been shown to have hypoglycaemic effect, however 
there test result is subjected to several factors. First each herb contains thousands of 
components, only a few of which may be therapeutically effective. Secondly extraction of 
active component is not easy (Karashima, 1988 and Angelova et al, 2008). Ebong et al., 2008 
showed clearly that medicinal plants formed the basis of health care throughout the world and 
have considerable importance. Some of these herbal preparations have been found to exert 
biological actions against diabetes mellitus and its complications (Ojiako and Nwanjo,2006). 
Alloxan induce diabetes by damaging the insulin secreting cells of the pancreas leading to 
hyperglycemia (Szuldelski at al 2001). 
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 Table 1 shows significant decrease in blood sugar level after periods of 7 and 14 days 
of treatment. The results showed that cinnamon extract exhibited a significant reduction 
(P<0.005) in blood glucose level of the diabetic male albino rats. The hypoglycaemic effect 
of cinnamon oil (CO) in a type 2 diabetic animal model was studied by Ping et al 2010 and 
according to their study CO was administrated at doses of 25, 50 and 100 mg/Kg for 35 days. 
They found that fasting blood glucose concentration was significantly decreased (p<0.05) 
with the 100 mg/Kg group (p<0.01) compared to diabetic control group. They observed that 
CO had a regulative role in blood glucose level and lipids, and improved the function of 
pancreatic islets. A number of other plants have been reported to have antihyperglycemic and 
insulin stimulatory effects.( Venkateswaran S, 2002 and Latha M, Pari L: 2003) 
 Graph 1 above shows that there was a significant reduction (P <0.005) in the body 
weight of group B untreated diabetic rats compared to other rats in other groups. This could 
be due to the defect in glucose metabolism and excessive breakdown of tissue protein which 
is a characteristic condition of diabetics (Swanston-Flat. et al 1990).      
 There was a significant reduction (P < 0.05) in WBC levels of diabetic rats treated 
with cinnamon aqueous extract compared to the untreated albino rats. This shows the abilities 
of the above treatment groups to curtail hematological abuses in the defense system of the 
diabetic rats. The study shows that there is a significant increase (p<0.005) in the level of 
RBC, HGB and HCT of group C and the treated groups compared to the untreated group 
(Table 2). These may be as a result of anemia or the onset of glycosylation process in the 
untreated diabetic rats (group B). The extract may not have adverse effects on the bone 
marrow, kidney and hemoglobin metabolism, since it has been reported that only substances 
which significantly affect the values of red blood cells and associated parameters would have 
effects on the bone marrow, kidney and hemoglobin metabolism (Young and Maciejewski 
1997).  The non– significant change (P<0.05) in the MCV and MCH values indicate absence 
of macrocytic anemia since increased in MCV an MCH values are known to be indicative of 
macrocytic anaemia. The extract also caused non- significant change in the MCHC value 
which suggests absence of hereditary spherocytosis since MCHC values are known to be 
elevated in hereditary spherocytosis. Other hematological parameters (RDW-CV, RDW-SD, 
PLT, MPV, PWD and PCT) showed no significant differences in the entire different group.  
 Table 3 shows that cinnamon extract  lowered plasma TC, TG, LDL-Chol levels and 
increase HDL-Chol concentrations in the treated rats, and this could account for its use in  
traditional medicine for the treatment of diabetes and hypertension. The results of this study 
clearly indicate that the administration of cinnamon extract produces hypoglycemic and 
hypolipidaemic effect and may prevent cardiovascular diseases. Studies have shown that 
increased in the risk factor of cardiovascular disease correlate with increase in plasma TC, 
TG, LDL-Chol, atherogenic index level and a decrease in HDL-Chol concentrations. The 
results of an experimental study show that cinnamaldehyde possesses hypoglycaemic and 
hypolipidemic effects in STZ-induced diabetic rats (Blevins et al 2007). This is in agreement 
with our studies. These results suggest that cinnamon aqueous extract has a regulatory role in 
reducing blood glucose level and lipids parameters. This may be due to blood glucose 
suppressing effect by improving insulin sensitivity or slowing absorption of carbohydrates in 
the small intestine. 
 The extract caused significant decrease (P<0.05) in the activity of AST, ALT and ALP 
values as shown in Figure 2-4. These indicate that the extract may reduce hepatic damage. In 
medicine, the presence of elevated values of ALT and AST is indicative of liver damage 
(Giboney, 2005). ALP levels in plasma rise as a result of large bile duct obstruction, 
intrahepatic cholestasis or infiltrative diseases of the liver. Increased level of ALP has been 
attributed to the damaged structural integrity of hepatic cells because the enzyme alkaline 
phosphatase is located in the cytoplasm and is released into the circulation after cellular 
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damage. The plasma total protein increases in the healthy group and treated groups compared 
to the untreated diabetic group (Figure 5).                                                                                                                                                                                                                                                                                                                                         
 
Conclusion 
 The results show that aqueous extract of cinnamon possesses hypoglycaemic effect, 
hypolipidemic properties and the extract is not hematotoxic and may reduce liver damage 
induced by alloxan.  
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